Get Free Genes
2013 Gen9 G-Prize
Announcement – Professor Farren Isaacs of Yale University is the winner of the 2013 G-Prize
One million base pairs!
As the Next Gen Gene Synthesis Company, Gen9 has developed an exceptional technology to synthesize DNA constructs using our award winning BioFab® technology. Today, Gen9 is manufacturing and shipping our GeneBits (500bp to 1000bp) and the longer GeneBytes (1kbp to 3kbp) to customers around the globe.
The G-Prize contest, conceived and exclusively sponsored by Gen9, was launched to foster creative and innovative approaches for using synthetic DNA libraries to constructively advance industries such as pharmaceuticals, chemicals, biofuels and agriculture. In 2012, the G-Prize judges identified five separate winners of the G-Prize, and Gen9 awarded those winners 1 million base pairs of dsDNA. This year, in order to further spark innovation in synthetic biology, Gen9 will award the whole 1 million base pairs to one research group!
The annual G-Prize contest is open to academic and non-profit scientists only.
COMMERCIAL COMPANIES: While this competition is offered to academic and non-profit scientists only, we welcome inquiries and potential collaborations with commercial companies interested in the power of the Gen9 BioFab® platform and how it can support your R&D efforts.
Please contact us to learn more.
The Gen9 G-Prize FAQ
If you don’t see your question below or need more information, please feel free to contact us.
Winners of the 2013 G-Prize will receive a free library of DNA constructs equaling one million base pairs! Each construct is a double-stranded gene fragment from 500 to 3000 base-pairs in length.
Any scientist from an academic or nonprofit institution may enter. Simply fill out the online application form with a description of how you would use the library of gene constructs. Submissions are due by November 1, 2013.
One grand prize winner will be chosen by the judges to win the whole one million base pairs.
A panel of judges has been chosen by Gen9 to review the entries and select our winner. The winner has been chosen and will announced any day now!
We accept entries from any organization or researcher who has a compelling and constructive use of synthetic biology. All gene sequences submitted will be kept confidential, but we will screen the sequence of every gene submitted by applicants to identify regulated and other potentially dangerous pathogen sequences, and to verify that our entrants are legitimate scientists engaged in beneficial research.